Unrated Drug recall · FDA · Published September 21, 2022

Akorn Rifampin Capsules Recall: Impurities May Cause Harm

Akorn recalls 150mg Rifampin Capsules due to impurities exceeding safety limits. This medication is prescription-only and may pose health risks if used.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #D-1547-2022Drug Akorn ›

Recall notice

Failed impurities/degradation specifications: Finished product exceeds the 5 ppm interim limit for 1-Methyl-4-Nitrosopoperazine (MNP).

Take action

Contact the company

Recalling firmAkorn, Inc.5605 Centerpoint Ct Ste A · Gurnee, IL 60031-5278

✎ GovInfoNow plain-language explainer

Akorn is recalling 150 mg Rifampin Capsules (30-count bottles) because they contain impurities that exceed safe levels. This could lead to health risks for people taking the medication as prescribed. Read more at govinfonow.com/recall/34317-akorn-rifampin-capsules-recall-impurities-may-cause-harm.

Source Summary by GovInfoNow · govinfonow.com/recall/34317-akorn-rifampin-capsules-recall-impurities-may-cause-harm · Updated August 18, 2026 · FDA enforcement record: FDA #D-1547-2022

Cite this page

“Akorn Rifampin Capsules Recall: Impurities May Cause Harm.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/34317-akorn-rifampin-capsules-recall-impurities-may-cause-harm. Based on FDA recall #D-1547-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1547-2022%22&limit=1).

The FDA announced on Sept. 21, 2022, that Akorn, Inc. is voluntarily recalling Rifampin Capsules, USP, 150 mg because finished products exceed the interim limit for a harmful impurity. Owners should contact the company for a refund.

How to tell if you have it

Brand: Akorn
Product: Rifampin Capsules, USP, 150 mg, 30-count bottle
NDC: 61748-015-30
Lot codes: 3192818 (Exp 10/31/2022), 3199700 (Exp 03/31/2023), 3203853 (Exp 02/29/2024)
Distributed by: Akorn Operating Company, LLC, Gurnee, IL
Distribution: USA Nationwide and Puerto Rico
Units affected: 18,145 bottles

The hazard

The recall is due to failed impurities and degradation specifications, specifically because the finished product exceeds the 5 ppm interim limit for 1-Methyl-4-Nitrosopoperazine (MNP).

Context

GovInfoNow's records show Akorn, Inc. has had 64 other recalls on record since Aug. 5, 2014. Other recent recalls of similar products include Akorn Rifampin Capsules 300mg Recall (2023-04-26), Akorn Atropine Sulfate Ophthalmic Solution 1% Recall (2023-01-30), and Akorn Ketorolac Ophthalmic Solution Recall (2022-10-13). Other recent recalls of similar products include Zydus Clomipramine Capsules Recall (2025-10-22), Asclemed Duloxetine Capsules Recall (2026-05-14), and Hikma Ramipril Capsules 10mg Recall (2026-08-24).

How to tell if you have this one

Check for the 150 mg Rifampin Capsules (30-count) with NDC 61748-015-30. Lot numbers 3192818 (exp 10/31/2022), 3199700 (exp 03/31/2023), or 3203853 (exp 02/29/2024).

Brand
Akorn
Category
Drug

FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

Classification
Class II
Status
Ongoing
Distribution
USA Nationwide and Puerto Rico

Recall number	Product, codes & lots	Quantity
D-1547-2022	Rifampin Capsules, USP, 150 mg, 30-count bottle, Rx only, Distributed by: Akorn Operating Company, LLC, Gurnee, IL 60031, NDC 61748-015-30; Lot#: 3192818, Exp 10/31/2022; 3199700, Exp 03/31/2023; 3203853, Exp 02/29/2024	18,145 bottles
D-1548-2022	Rifampin Capsules, USP, 300 mg, a) 30-count bottle (NDC 61748-018-30), b) 60-count bottle (NDC 61748-018-60), c) 100-count bottle (NDC 61748-018-01), Rx only, Distributed by: Akorn Operating Company, LLC, Gurnee, IL 60031.; Lot#: a) 3192827, Exp 10/31/2022; 3196136, Exp 12/31/2022; 3202198, Exp 07/31/2023; 3203658, Exp 07/31/2023; 3209114, Exp 11/30/2023; 3203851, Exp 02/29/2024; b) 3191254, Exp 09/30/2022; 3192820, Exp 09/30/2022; 3192822, Exp 10/31/2022; 3192824, Exp 10/31/2022; 3192825, Exp 10/31/2022; 3196141, Exp 01/31/2023; 3196143, Exp 02/28/2023; 3203870, Exp 11/30/2023; 3203871, Exp 02/29/2024; c) 3190636, Exp 09/30/2022; 3192813, Exp 09/30/2022; 3196132, Exp 12/31/2022; 3196133, Exp 12/31/2022; 3196138, Exp 01/31/2023; 3199702, Exp 03/31/2023; 3199703, Exp 03/31/2023	177,439 bottles

Based on the official FDA remedy

What to do — step by step

Check Medication Details
Look for the NDC code 61748-015-30 and specific lot numbers listed in the recall notice.

Where it went and when

Where it was distributed

Distributed nationwide.

FDA distribution: “USA Nationwide and Puerto Rico” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 14 days after the firm started it.

Sep 21, 2022Firm started the recall
Sep 28, 2022FDA classified it Class II
Oct 5, 2022Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Link to this recall

<a href="https://govinfonow.com/recall/34317-akorn-rifampin-capsules-recall-impurities-may-cause-harm">Akorn Rifampin Capsules Recall: Impurities May Cause Harm (GovInfoNow)</a>

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

Official source: FDA Recall #D-1547-2022 (September 21, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1547-2022 to see it in context.
Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.